183 related articles for article (PubMed ID: 35089587)
21. Restoration of MAGI-1 expression in human papillomavirus-positive tumor cells induces cell growth arrest and apoptosis.
Kranjec C; Massimi P; Banks L
J Virol; 2014 Jul; 88(13):7155-69. PubMed ID: 24696483
[TBL] [Abstract][Full Text] [Related]
22. Degradation of tyrosine phosphatase PTPN3 (PTPH1) by association with oncogenic human papillomavirus E6 proteins.
Jing M; Bohl J; Brimer N; Kinter M; Vande Pol SB
J Virol; 2007 Mar; 81(5):2231-9. PubMed ID: 17166906
[TBL] [Abstract][Full Text] [Related]
23. The FERM and PDZ domain-containing protein tyrosine phosphatases, PTPN4 and PTPN3, are both dispensable for T cell receptor signal transduction.
Bauler TJ; Hendriks WJ; King PD
PLoS One; 2008; 3(12):e4014. PubMed ID: 19107198
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the Human Phosphatase PTPN4 by the inter-domain linker connecting the PDZ and the phosphatase domains.
Caillet-Saguy C; Toto A; Guerois R; Maisonneuve P; di Silvio E; Sawyer K; Gianni S; Wolff N
Sci Rep; 2017 Aug; 7(1):7875. PubMed ID: 28801650
[TBL] [Abstract][Full Text] [Related]
25. Interactions of the protein tyrosine phosphatase PTPN3 with viral and cellular partners through its PDZ domain: insights into structural determinants and phosphatase activity.
Genera M; Colcombet-Cazenave B; Croitoru A; Raynal B; Mechaly A; Caillet J; Haouz A; Wolff N; Caillet-Saguy C
Front Mol Biosci; 2023; 10():1192621. PubMed ID: 37200868
[TBL] [Abstract][Full Text] [Related]
26. Mitotic control of human papillomavirus genome-containing cells is regulated by the function of the PDZ-binding motif of the E6 oncoprotein.
Marsh EK; Delury CP; Davies NJ; Weston CJ; Miah MAL; Banks L; Parish JL; Higgs MR; Roberts S
Oncotarget; 2017 Mar; 8(12):19491-19506. PubMed ID: 28061478
[TBL] [Abstract][Full Text] [Related]
27. A systematic analysis of human papillomavirus (HPV) E6 PDZ substrates identifies MAGI-1 as a major target of HPV type 16 (HPV-16) and HPV-18 whose loss accompanies disruption of tight junctions.
Kranjec C; Banks L
J Virol; 2011 Feb; 85(4):1757-64. PubMed ID: 21123374
[TBL] [Abstract][Full Text] [Related]
28. Solution structure of the hDlg/SAP97 PDZ2 domain and its mechanism of interaction with HPV-18 papillomavirus E6 protein.
Liu Y; Henry GD; Hegde RS; Baleja JD
Biochemistry; 2007 Sep; 46(38):10864-74. PubMed ID: 17713926
[TBL] [Abstract][Full Text] [Related]
29. Surface plasmon resonance analysis of the binding of high-risk mucosal HPV E6 oncoproteins to the PDZ1 domain of the tight junction protein MAGI-1.
Fournane S; Charbonnier S; Chapelle A; Kieffer B; Orfanoudakis G; Travé G; Masson M; Nominé Y
J Mol Recognit; 2011; 24(4):511-23. PubMed ID: 20842623
[TBL] [Abstract][Full Text] [Related]
30. Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.
Conrady MC; Suarez I; Gogl G; Frecot DI; Bonhoure A; Kostmann C; Cousido-Siah A; Mitschler A; Lim J; Masson M; Iftner T; Stubenrauch F; Travé G; Simon C
J Virol; 2020 Dec; 95(2):. PubMed ID: 33115863
[TBL] [Abstract][Full Text] [Related]
31. Design of a PDZbody, a bivalent binder of the E6 protein from human papillomavirus.
Karlsson OA; Ramirez J; Öberg D; Malmqvist T; Engström Å; Friberg M; Chi CN; Widersten M; Travé G; Nilsson MT; Jemth P
Sci Rep; 2015 Mar; 5():9382. PubMed ID: 25797137
[TBL] [Abstract][Full Text] [Related]
32. Human Papillomavirus E6 interaction with cellular PDZ domain proteins modulates YAP nuclear localization.
Webb Strickland S; Brimer N; Lyons C; Vande Pol SB
Virology; 2018 Mar; 516():127-138. PubMed ID: 29346075
[TBL] [Abstract][Full Text] [Related]
33. Regulation of the catalytic activity of the human phosphatase PTPN4 by its PDZ domain.
Maisonneuve P; Caillet-Saguy C; Raynal B; Gilquin B; Chaffotte A; Pérez J; Zinn-Justin S; Delepierre M; Buc H; Cordier F; Wolff N
FEBS J; 2014 Nov; 281(21):4852-65. PubMed ID: 25158884
[TBL] [Abstract][Full Text] [Related]
34. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
[TBL] [Abstract][Full Text] [Related]
35. Cancer-causing human papillomavirus E6 proteins display major differences in the phospho-regulation of their PDZ interactions.
Boon SS; Tomaić V; Thomas M; Roberts S; Banks L
J Virol; 2015 Feb; 89(3):1579-86. PubMed ID: 25410862
[TBL] [Abstract][Full Text] [Related]
36. Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31.
Lee C; Laimins LA
J Virol; 2004 Nov; 78(22):12366-77. PubMed ID: 15507623
[TBL] [Abstract][Full Text] [Related]
37. The role of protein kinase A regulation of the E6 PDZ-binding domain during the differentiation-dependent life cycle of human papillomavirus type 18.
Delury CP; Marsh EK; James CD; Boon SS; Banks L; Knight GL; Roberts S
J Virol; 2013 Sep; 87(17):9463-72. PubMed ID: 23804647
[TBL] [Abstract][Full Text] [Related]
38. The structural and dynamic response of MAGI-1 PDZ1 with noncanonical domain boundaries to the binding of human papillomavirus E6.
Charbonnier S; Nominé Y; Ramírez J; Luck K; Chapelle A; Stote RH; Travé G; Kieffer B; Atkinson RA
J Mol Biol; 2011 Mar; 406(5):745-63. PubMed ID: 21238461
[TBL] [Abstract][Full Text] [Related]
39. The E6 oncoprotein from HPV16 enhances the canonical Wnt/β-catenin pathway in skin epidermis in vivo.
Bonilla-Delgado J; Bulut G; Liu X; Cortés-Malagón EM; Schlegel R; Flores-Maldonado C; Contreras RG; Chung SH; Lambert PF; Uren A; Gariglio P
Mol Cancer Res; 2012 Feb; 10(2):250-8. PubMed ID: 22160870
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus type 8 E6 oncoprotein inhibits transcription of the PDZ protein syntenin-2.
Lazić D; Hufbauer M; Zigrino P; Buchholz S; Kazem S; Feltkamp MC; Mauch C; Steger G; Pfister H; Akgül B
J Virol; 2012 Aug; 86(15):7943-52. PubMed ID: 22623796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
